检索结果 - Darshan Roy
- Showing 1 - 3 results of 3
-
1
-
2
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases 由 Yashodhara Dasgupta, Mateusz Koptyra, Grażyna Hoser, Kanchan Kantekure, Darshan Roy, Barbara Górnicka, Margaret Nieborowska-Skorska, Elisabeth Bolton-Gillespie, Sabine Cerny‐Reiterer, Markus Müschen, Peter Valent, Mariusz A. Wasik, Christine Richardson, Oliver Hantschel, Heiko van der Kuip, Tomasz Stokłosa, Tomasz Skórski
出版 2016Artigo -
3
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile 由 Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, Michelle R. Padget, David Irvine, Tomasz Śliwiński, Kimberly Haas, Jae Woong Lee, Huimin Geng, Darshan Roy, Artur Słupianek, Feyruz V. Rassool, Mariusz A. Wasik, Wayne E. Childers, Mhairi Copland, Markus Müschen, Curt I. Civin, Tomasz Skórski
出版 2013Artigo
相关主题
Biology
Cancer research
Cell biology
DNA
DNA damage
Gene
Genetics
Molecular biology
ABL
Cancer
Carcinogenesis
Cell cycle
Chronic myelogenous leukemia
Cyclin
Cyclin A
Cyclin A2
Cyclin B
Cyclin D
Cyclin D1
Cyclin E
Cyclin E1
DNA repair
Dasatinib
Genome instability
Homologous recombination
Imatinib
Imatinib mesylate
Immunology
Kinase
Leukemia